(Washington, D.C.) — The Pharmaceutical Care Management Association released the following statement on the Pennsylvania Auditor General’s report, “Bringing Transparency & Accountability to Drug Pricing:” “The Pennsylvania Auditor General has released yet another biased report on pharmacy benefit managers (PBMs).
Varbah Flumoku Executive Assistant, State Affiars Varbah Flumoku is the Executive Assistant, State Affairs for the Pharmaceutical Care Management Association (PCMA). In this role she provides operational support for the State Affairs Team. Previously, she served as the Executive Assistant
JC Scott speaks with Doug Long, Vice President of Industry Relations at IQVIA, about the impact of COVID-19 on the pharmaceutical market. IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Health and Human Services Office of Inspector General’s proposed rule on prescription drug rebates in Medicare: “While we are reviewing the proposed
PBMs Support and Encourage Biosimilar Competition Increased biosimilar competition drives down prescription drug costs Having multiple biosimilar and reference biologic competitor products with equivalent patient benefits on the market allows pharmacy benefit companies, PBMs, to push manufacturers to compete on
Katie Payne Senior Vice President, Public Affairs and Head of Advocacy Katie (Carr) Payne is Senior Vice President, Public Affairs and Head of Advocacy at PCMA. In this role, Katie is responsible for leading PCMA’s communications function and oversees the association’s
Agnita Kote Chief Financial Officer Agnita Kote is the Chief Financial Officer for PCMA. She provides strategic financial planning and management of PCMA’s financial affairs. Agnita has more than a decade of finance and accounting experience. Prior to joining PCMA, she
Brynn Hadley Senior Director, Conferences Brynn Hadley is Senior Director, Conferences at PCMA. She has more than 15 years of event planning experience. Most recently she was the Head of Conferences and Education at the American Frozen Food Institute where
The Visante study highlights top selling Medicare Part D brand-name drugs with steady price increases and no change in rebate levels over a five-year period from 2012 to 2017. In addition, the study analyzes a number of Medicare Part B
(Washington, D.C.) — The Pharmaceutical Supply and Payment Chain Coalition issued the following statement in response to the Administration’s 100-day review of the actions needed to address vulnerabilities in our nation’s pharmaceutical supply chain and what measures need to be taken in order
©2024 PCMA. All Rights Reserved.
